About Biojo Sciences
Biojo Sciences is a global biopharmaceutical company developing novel clinical-stage therapies that improve patient and family lives. Our approach offers an efficient development process by finding and delivering compelling clinical-stage biotechnologies through effective operations in an innovative portfolio biotech company. We invest in bringing early-stage drug assets to commercialization. Our members have rich industry knowledge in the latest science, regulatory pathways, and business strategies. Additionally, our portfolio targets a wide range of diseases and technologies, including oncology, neurology, rare diseases as well as cell & gene platforms.
Our mission at Biojo Sciences is to focus on creating therapeutic value for patients, for innovative science, and for our stakeholders.
Jenny (Seungyun) Jo
Founder & CEO